Tibra Equities Europe’s Sanofi SNY Stock Holding History

Tibra Equities Europe’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-11,000	Closed	-$534K	–	116
2020 Q4	$534K	Buy	+11,000	New	+$543K	0.05%	116

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Tibra Equities Europe's SNY Position: Q1 2021 in Review

Tibra Equities Europe sold out of Sanofi (SNY) in Q1 2021, closing a stake of 11,000 shares — an estimated $534K sold.

Tibra Equities Europe first reported a position in SNY in Q4 2020 and held it in 1 quarter. The position peaked at $534K in Q4 2020. 572 funds tracked by Wall St. Rank hold SNY as of Q1 2021.

Tibra Equities Europe reported no remaining Sanofi position as of Q1 2021 after selling out during the quarter.
Tibra Equities Europe sold 11,000 Sanofi shares in Q1 2021, an estimated $534K.
Tibra Equities Europe first reported a position in Sanofi in Q4 2020 and held it in 1 quarter.
Tibra Equities Europe's Sanofi position peaked at $534K in Q4 2020.
572 funds tracked by Wall St. Rank held Sanofi as of Q1 2021.

Based on Tibra Equities Europe's 13F filing for Q1 2021, filed 17 May 2021.